| Period Ending |
Dec 31, 2014 |
Sep 30, 2014 |
Jun 30, 2014 |
Mar 31, 2014 |
| Total Revenue |
0 |
1 |
– |
– |
| Cost of Revenue |
– |
– |
– |
– |
|
| Gross Profit |
0 |
1 |
– |
– |
|
|
Operating Expenses |
|
Research Development |
– |
– |
– |
– |
|
Selling General and Administrative |
– |
– |
– |
– |
|
Non Recurring |
– |
– |
– |
– |
|
Others |
– |
– |
– |
– |
|
|
|
Total Operating Expenses |
– |
– |
– |
– |
|
|
| Operating Income or Loss |
3,009 |
(2,995) |
(130) |
(130) |
|
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
(199) |
– |
– |
– |
|
Earnings Before Interest And Taxes |
2,811 |
(2,999) |
(130) |
(130) |
|
Interest Expense |
(5,788) |
6,328 |
– |
– |
|
Income Before Tax |
8,598 |
(9,328) |
(130) |
(130) |
|
Income Tax Expense |
– |
– |
– |
– |
|
Minority Interest |
– |
– |
– |
– |
|
|
|
Net Income From Continuing Ops |
8,598 |
(9,328) |
(130) |
(130) |
|
|
Non-recurring Events |
|
Discontinued Operations |
– |
– |
– |
– |
|
Extraordinary Items |
– |
– |
– |
– |
|
Effect Of Accounting Changes |
– |
– |
– |
– |
|
Other Items |
– |
– |
– |
– |
|
|
| Net Income |
8,598 |
(9,328) |
(130) |
(130) |
| Preferred Stock And Other Adjustments |
– |
– |
– |
– |
|
| Net Income Applicable To Common Shares |
8,598 |
(9,328) |
(130) |
(130) |
|